Most Recent Articles by Carlos Harrison
Several promising drugs have been approved for the treatment of bladder cancer within the phase year, but combination therapies may be still more effective.
Strategies that work for patients with CML fail for aCML cases, though some new research is promising.
Researchers argue that children with CML should receive different treatments than adults, which may mitigate long-term side effects.
Melanoma treatment has improved dramatically in the past decade, and new advancements are already on the horizon.
The role of WBRT for brain metastases is unclear with the advent of new and emerging treatments.
More Articles by Carlos Harrison
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|
|Renal Cell Carcinoma||Regimens||Drugs|
Cancer Therapy Advisor Articles
- In Focus: Atezolizumab for Non-small Cell Lung Cancer
- FDA Warns 14 Companies To Stop Selling Illegal Cancer Treatments
- ASCO Releases Opinion on Hormonal Therapy for Castrate-resistant Prostate Cancer
- Pembrolizumab for Advanced Melanoma: Efficacy and Toxicity
- Bladder Cancer: Immunotherapies, Combination Therapies, and Current Research